During myelination, individual oligodendrocytes initially overproduce short myelin sheaths, which are either retracted or stabilized. By live-imaging oligodendrocyte Ca 2+ activity in vivo, we find that high-amplitude, long-duration Ca 2+ transients in sheaths prefigure retractions, mediated by calpain. Following stabilization, myelin sheaths grow along axons, and we find that higher-frequency Ca 2+ transient activity in sheaths precedes faster elongation. Our data implicate local Ca 2+ signaling in regulating distinct stages of myelination.
individual oligodendrocytes with a time interval of 2.5 s ( Fig. 1a -e, Methods, Supplementary Fig. 2 and Supplementary Videos 2 and 3).
To correlate Ca 2+ activity with myelination, we time-lapseimaged individual GCaMP6s-expressing oligodendrocytes for multiple 20-min blocks over a 5-to 9-h period during which they initiated formation and elongation of their myelin sheaths ( Fig. 1f,g ). Prior to each Ca 2+ imaging block, we acquired a highresolution 3D z-stack of GCaMP6s-expressing oligodendrocytes together with sox10:mRFP, which allowed assessment of sheath morphology (Fig. 1f ,g and Methods). We quantified the Ca 2+ activity of 305 sheaths of 18 oligodendrocytes in 18 animals. Analyses of 448 Ca 2+ transients in the 187 sheaths that exhibited activity (of the 305 sheaths imaged) revealed substantial diversity in the frequency (Fig. 1h ), amplitude and duration of transients between sheaths ( Fig. 1i ,j; median amplitude per sheath, ∆F/F 0 = 0.7; interquartile range = 0.9; median Ca 2+ transient duration = 23 s, interquartile range = 17 s per sheath). We also found that duration and amplitude were positively correlated, while longer duration transients tended to also be of higher amplitude (Fig. 1k ).
The diversity in Ca 2+ transient activity between sheaths suggested that their frequency, duration and/or amplitude may influence myelination. We first focused on the relationship between Ca 2+ activity and myelin sheath formation. We found that 61 of the 305 sheaths analyzed were completely retracted during our imaging protocol, reflecting the initial over-production of sheaths. Notably, we found that the amplitude of Ca 2+ transients in sheaths that were subsequently retracted was threefold higher than in those sheaths that were stabilized ( Fig. 2a,b,d ; median amplitude, ∆F/F 0 = 1.8 in fully retracted sheaths versus ∆F/F 0 = 0.6 in stabilized sheaths). Furthermore, we observed an increase in Ca 2+ transient duration in sheaths that were subsequently retracted ( Fig. 2c,d ; median duration = 35 s in retracted sheaths versus 22 s in stabilized). Notably, the Ca 2+ transients observed in sheaths that were subsequently retracted traveled from sheath to process ( Supplementary Fig. 3 and Supplementary Video 4), reflecting the directionality of retraction, first of the sheath and then the process ( Fig. 2a and Supplementary  Fig. 4 ). These observations led us to hypothesize that localized high-amplitude, long-duration Ca 2+ transients may mediate sheath retraction through activation of Ca 2+ -dependent mechanisms.
We hypothesized that calpain enzymes, Ca 2+ -dependent nonlysosomal proteases, might mediate sheath retraction. Calpains underpin many aspects of cellular breakdown, including the localized pruning of dendrites in Drosophila melanogaster following large Ca 2+ transients 14 . To test whether calpain mediates myelin sheath retractions, we took chemical and genetic approaches. We first treated zebrafish with the calpain inhibitor PD150606 15 from 2 to 4 dpf and assessed the morphology of individual oligodendrocytes with mbp:mCherry-CAAX 6 . We found that PD150606 treatment increased myelin sheath number per oligodendrocyte ( Fig. 2e ,h; average sheath number per oligodendrocyte: DMSO, 14.4 ± 3.2 versus PD150606, 18.7 ± 5.9). To determine whether calpain actually mediates retraction of sheaths, we carried out time-lapse microscopy of PD150606-treated animals. These studies revealed a lower rate of sheath retraction in calpain-inhibited animals during the dynamic period of sheath stabilization and retraction (Fig. 2f ,i and Supplementary Videos 5 and 6; sheath retraction per oligodendrocyte per h: DMSO, 0.34 ± 0.13 versus PD150606, 0.24 ± 0.13). To independently and cell-autonomously test the role of calpain in regulating myelin sheath number, we expressed the endogenous inhibitor of calpain, calpastatin 16 , in myelinating oligodendrocytes (see Methods and Supplementary  Fig. 5 ). Analysis of oligodendrocyte morphology revealed that cell-type-specific disruption of calpain protease function increased the number of myelin sheaths compared to control ( Fig. 2g ,j; average sheath number per cell: control (mbp:meGFP), 15.8 ± 6.4 versus mbp:meGFP-calpastatin 20.5 ± 5.8). Together, these data support our imaging-driven hypothesis that calpain regulates retraction of myelin sheaths during the dynamic period of myelin sheath formation by individual oligodendrocytes.
We next assessed how Ca 2+ transient activity might relate to myelin sheath growth. By comparing Ca 2+ activity and differential growth over time ( Fig. 3a,b ), we found that the frequency of the lower-amplitude, shorter-duration Ca 2+ transients observed in stabilized sheaths correlated positively with the speed of sheath elongation ( Fig. 3c,d ). When we analyzed how individual sheaths grew after each Ca 2+ transient, we observed positive elongation within 2 h of the Ca 2+ transient (Fig. 3e ). We did not see any correlation between the average amplitude or duration of transients with the speed of growth ( Supplementary Fig. 6 ). These observations show that the frequency of low-amplitude, short-duration Ca 2+ transients in stabilized sheaths is predictive of their speed of elongation, suggesting that dynamic changes in myelin sheath Ca 2+ concentration regulate sheath growth.
Our live imaging revealed distinct signatures of localized Ca 2+ activity during CNS myelination. High-amplitude, long-duration Ca 2+ transients preceded localized retraction of sheaths, mediated by calpain, whereas the frequency of lower-amplitude, shorterduration transients in stabilized sheaths correlated positively with their speed of elongation (summarized in Supplementary Fig. 7 ). How could distinct Ca 2+ signatures lead to such different outcomes during myelination? With respect to sheath retraction, it is known that different isoforms of calpain have distinct sensitivities to Ca 2+ concentration, with some primed for activation by localized changes in Ca 2+ concentration 17 . It is possible that large localized increases in Ca 2+ concentration following individual high-amplitude, longduration transients could stimulate local protease activity that leads to sheath retraction, for example, by localized degradation of cytoskeletal components. With respect to the speed of sheath elongation, it is now known that myelin sheath growth is driven, at least in part, by iterative cycles of actin polymerization and depolymerization 18 . Given that actin polymerization and depolymerization can be regulated by Ca 2+ , it is possible that localized changes in Ca 2+ concentration could affect the speed of sheath growth via regulating the actin cytoskeleton. Many additional questions remain as to how localized Ca 2+ regulates myelination. Which signal(s) lead to the distinct changes in myelin sheath Ca 2+ during retraction, stabilization and growth? Neuronal activity is one signal known to affect myelination 5,8-10 , and many of its candidate mediators in oligodendrocytes converge on regulation of intracellular Ca 2+19 . Indeed, a study complementary to ours indicates that neuronal activity regulates about half of the Ca 2+ transients in myelin 20 . How Ca 2+ might affect ongoing sheath growth and remodeling throughout life, and during regeneration, also remains to be investigated. We anticipate that live Ca 2+ imaging-focused approaches will continue to elucidate the mechanisms underlying the dynamic regulation of myelination in the CNS.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-017-0040-x. 
Zebrafish husbandry. All animal studies were carried out with approval from the UK Home Office and according to its regulations, under project licenses 60/4035 and 70/8436. The project was approved by the University of Edinburgh Institutional Animal Care and Use Committee. We used zebrafish (Danio rerio) only, and the following transgenic lines in this study: Tg(sox10:KalTA4) 21 , Tg(uas:meGFP), Tg(uas:GCaMP6s) 13 and Tg(sox10:mRFP) 22 . All Ca 2+ imaging was carried out in the nacre background 23 , which lack melanocytes.
Image acquisition. We combined stable transgenic zebrafish Tg(sox10:KalTA4), which drives gene expression in the oligodendrocyte lineage, with Tg(uas:GCaMP6s), which expresses the genetically encoded calcium indicator GCaMP6s under the control of 14 repetitive upstream activator sequences (uas), the nacre homozygous mutant line, which lacks melanocytes, and Tg(sox10:mRFP), which drives membrane-localized RFP expression in the myelinating oligodendrocyte lineage. The combination of Tg(sox10:KalTA4) and Tg(uas:GCaMP6s) leads to mosaic expression of GCaMP6s in isolated cells of the oligodendrocyte lineage in the CNS.
Prior to imaging, larvae were screened for the expression of GCaMP6s in isolated oligodendrocytes in the dorsal spinal cord at 3-4 days post fertilization (dpf). Selected larvae were paralyzed using the neuromuscular junction (NMJ)blocking nicotinic receptor antagonist pancuronium bromide (Sigma, P1918), which was dissolved in embryo medium (0.15-0.3 mg/mL). Larvae were then embedded in 1.3% agarose for imaging. Imaging was carry out on an Olympus Revolution XDi spinning disk confocal microscope using a 1.2 NA 60× water immersion objective, plus a camera zoom of 2×, giving an xy image area of 117 × 117 µm and acquisition at 512 × 512 pixels. Larvae were maintained at 28 °C in a temperature-controlled chamber (Okolab). Images were acquired using iQ3 software (Andor) and an iXon EMCCD Ultra 897 camera.
For initial 2D characterization of calcium transient kinetics, Tg(sox10:KalTA4, uas:GCaMP6s), Tg(sox10:mRFP) larvae were time-lapse-imaged for periods of 10-30 min, with 100-ms exposure times and 150-to 250-ms intervals, reflecting imaging in one (GCaMP6s) or two (GCaMP6s and mRFP) channels, for a final rate of 4-6.66 Hz (final rates also incorporate camera integration times).
To investigate how Ca 2+ activity related to cell fate, Tg(sox10:KalTA4, uas:GCaMP6s, sox10:mRFP), nacre −/− larva were imaged every 60-120 min as follows. First, one high-resolution 3D 29-µm deep (average ± 2 µm) z-stack of both RFP and GCaMP6s expression was acquired at 100-ms exposure, 4× averaging, and z-intervals of 0.33 µm between optical slices. Immediately thereafter, 3D timelapse images of GCaMP6s expression alone were acquired of the same 29-µm (±2 µm) volume, at 100 ms exposure (no averaging) and a z-step of 1.3 µm. The time interval between consecutive z-stacks in the time-lapse was 2.538 s (±0.264 s), including z-positioning and camera integration times. Absolute values of imaging parameters were incorporated into analyses of all individual Ca 2+ transients and time-lapse data.
Image analysis. Two-dimensional time-lapse imaging data were analyzed using Fiji. To correct for sample drift throughout the movie we used the 'image stabilizer registration' Fiji plugin (Kang Li). Because of the very sparse labeling of individual GCaMP6s-expressing oligodendrocytes, it was possible to identify Ca 2+ transients by manual inspection of time-lapse series. Regions of interest were then applied around all myelin sheaths and also in a separate area with no GCaMP6s expression, which we used to represent background. Then fluorescent intensity measurements were extracted from both ROIs and imported into Excel. To measure ∆F/F 0 we applied the following formula:
where F t is the fluorescence intensity in the ROI in which the Ca 2+ transient was observed at time t, F 0 is the average fluorescence intensity of the first four frames of the movie in the same ROI, and F background is the fluorescence intensity of the background ROI at time t. See Supplementary Fig. 1 for an overview. This ∆F/F 0 information and corresponding image-acquisition parameters were imported into pClamp (Molecular Devices) for detailed analyses of the duration and amplitude of individual Ca 2+ transients.
For 3D time-lapse imaging data, maximum intensity projections of the individual time-points from 3D time-lapse data were made using Fiji, and the image stabilizer Fiji plugin was again run to account for drift. In parallel, 3D datasets were registered using the 'descriptor-based series registration (2d/3d + t)' Fiji plugin, after which maximum intensity projections were made and Ca 2+ transients identified manually. Only Ca 2+ transients identified following both modes of image processing were considered as valid. All myelin sheaths without overlapping structures in the xy or z planes were analyzed. Regions of interest were then applied around all myelin sheaths and corresponding background, as above. In addition, the ROI with the candidate Ca 2+ transient was moved to an immediately adjacent region to rule out the possibility that any, very infrequent, general increase in background fluorescence in the region could identify a spurious transient. Key parameters for analysis of 3D time-lapse datasets were extracted from the iQ3 metadata files using a custom Fiji macro written by B. Vernay (University of Edinburgh). These parameters were then imported into Microsoft Excel for analysis. All Ca 2+ transients were identified by ∆F/F 0 , as above, and analyzed using pClamp.
To measure myelin sheath length, we used the 3D high-resolution single-time z-stack datasets acquired before each period of GCaMP6s time-lapse imaging. The expression of GCaMP6s allowed identification of individual myelin sheaths, and the membrane-localized mRFP in the same sheaths allowed more accurate measurement of length.
Calpain inhibitor treatment and analysis. The calpain inhibitor PD150606 (Tocris) was applied in solution, 50-75 µM, with 1% DMSO to embryos 2-4 dpf; vehicle alone was applied to controls. The morphology of myelinating oligodendrocytes was assessed as previously described, by imaging individual oligodendrocytes expressing the mbp:mCherry-CAAX reporter 6 . Images of individual myelinating oligodendrocytes were taken on a Zeiss 880 with Airyscan, in animals immobilized using 1.3% low-melting-point agarose with 0.03% Tricaine in embryo medium. Individual myelin sheaths were identified in 3D z-stacks and measured using Fiji. Time-lapse analyses were carried out using Tg(sox10(7.2):KalTA4GI), Tg(uas:meGFP) animals, which were imaged on a Zeiss 880 Airyscan in Fast mode and with a piezo z-drive to allow rapid acquisition of confocal z-stacks. Z-stack images were collected every 5 min for a 15-h period 81-96 hpf.
Cell-type-specific expression of calpastatin in myelinating oligodendrocytes.
To disrupt calpain function in a cell type specific manner, we chose to express the endogenous inhibitor of calpain calpastatin 24 in myelinating oligodendrocytes. We first cloned zebrafish calpastatin. To do so, we extracted mRNA from whole zebrafish embryos at 3 and 4 dpf, generated cDNA and amplified calpastatin using the following primers castF: 5′-ATGGCGTACGCAATGTATTGG-3′; castR: 5′-TTATCTTTTTCCAGCCTTTGTGG-3′ and high-fidelity Phusion polymerase (Thermo Fisher). We cloned cast fragments into pCR-Blunt II-TOPO (Thermo Fisher) and Sanger sequenced clones (Source Bioscience). We subcloned multiple-cast mRNA variants into pCS2+ and generated synthetic mRNA, which we injected into animals at the one-cell stage to identify a full-length version that led to an increase in myelin sheath numbers per oligodendrocyte in the dorsal spinal cord ( Supplementary Fig. 5 and data not shown). We next generated a p3E vector in which the full-length cast was flanked by p2A and a SV40 polyA sequences. We then generated a pME vector with the Fyn myristoylation domain added to green fluorescent protein (GFP) by amplifying GFP from pCS2+ eGFP and adding the myristoylation sequence using the following primer: meGFPF 5′-ATGGGCTGTGTGCAATGTAAGGATAAAGAAGCAACAAAACTGACG-3′ to generate a membrane-tethered GFP (meGFP). To generate a construct for celltype-specific expression of meGFP-pA or meGFP-2A-cast-pA we recombined the previously described p5E-mbp plasmid, containing zebrafish myelin basic protein (mbp) regulatory sequence 25 , with pME-meGFP and p3E-pA or with pME-meGFP and p3E-2A-cast-pA. We injected mbp:meGFP-pA (5 pg) or mbp:meGFP-2A-cast-p2A (10 pg) plasmids into zebrafish at the single-cell or two-cell stage, together with 25 pg tol2 mRNA 26 . Individual oligodendrocytes were imaged at 4 dpf using meGFP on a Zeiss 880 Airyscan confocal microscope in Fast mode.
Statistics and reproducibility. All data are shown as mean ± s.d. or median with first and third quartiles, as indicated. Please see Supplementary Table 1 for data on confidence levels and intervals related to raw data. All statistical tests were carried out using GraphPad (Prism 6 or 7). Power calculations were calculated using Statemate 2 for Ca 2+ imaging analyses and for investigations of the role of calpain signaling in myelination. All analyses had a power >80%. Randomization of imaging and analyses was not carried out on animals whose myelin sheaths were Ca 2+ imaged, as all were wild-type animals. For chemical and genetic manipulations of calpain function, zebrafish embryos for both experimental and control conditions derived from the same clutch (per experiment). For time-lapse analyses of chemical inhibitor treated animals, control and experimental animals were imaged separately for technical reasons. Experimental and control embryos were raised in the same incubator and the same conditions before analyses, and all imaging was done on live animals. During live imaging analyses, experimental and control animals were imaged in an alternating pattern (per experiment) to ensure no confounding effects of stage of development between groups. The analyses of all experimental findings were carried out blinded, and image data was randomized using a custom-made script.
The data shown in Supplementary Fig. 1 is representative of 20 myelin sheaths imaged in 12 animals over 4 separate experimental sessions. The data shown in Fig. 1a-e and Supplementary Fig. 2 are representative of 40 oligodendrocytes imaged in 40 animals over 25 separate occasions. The images analyzed and data presented in Figs. 1g-k, 2a-d and 3 are representative of 18 cells imaged over 9 separate experimental sessions. The images analyzed and data presented in Fig. 2e ,h are representative of 4 experimental sessions. The images analyzed and data presented in Fig. 2g ,j are representative of 4 experimental sessions. The images analyzed and data presented in Fig. 2f This is a first in kind study imaging Ca2+ activity in myelin sheaths in vivo using zebrafish. Therefore, it was not possible to do power calculations prior to the study, as the nature of the signalling and its variability was unknown. For these Ca2 + imaging experiments we imaged 18 animals and a total of 305 myelin sheaths, 187 of which showed activity. Analysis of variation indicated diverse Ca2+ activity between individual sheaths, and so "n" in the Ca2+ imaging experiments relates to individual sheaths. For our analyses of how manipulations of calpain signalling (chemical and genetic) affect myelination by individual oligodendrocytes, we carried out power calculations, and all experiments documented in Figure 2 and Supplementary 6 had a power >80%.
Data exclusions
Describe any data exclusions. No data were excluded.
Replication
Describe whether the experimental findings were reliably reproduced.
All findings were reproduced in at least two different experimental replicates. The details of experimental replicates are indicated in the appropriate figure legends.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
No randomisation was carried out on animals whose myelin sheaths were Ca2+ imaged, as all are wildtype-no experimental manipulation. For chemical and genetic manipulations, zebrafish embryos for both experimental and control conditions derived from the same clutch (per experiment). For time-lapse analyses of chemical inhibitor treated animals, control and experimental animals were imaged separately for technical reasons. Embryos were grown up in the same incubator and the same conditions prior to analyses, all live imaging. During live imaging analyses, experimental and control animals were imaged in an alternating pattern (per experiment) to ensure no confounding effects of stage of development between groups.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The analysis of all experimental findings were carried out blinded and image data was randomised using a custom-made script.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
